prednisone,certolizumab,natalizumab,ustekinumab,risankizumab,infliximab,vedolizumab
abbvie,ucb pharmaceuticals,takeda,janssen,boehringer ingelheim,biogen
['inflammatory,bowel', 'vedo', 'vedolizumab', 'prednisone', 'natalizumab', 'crohn', 'infliximab', ' vedo', 'methotrexate', 'ustekinumab', 'certolizumab', 'risan']
 on treatment sequencing in cd #ecco2023 note: key factors may be dynamic over time. 
Professor of Medicine, Gastroenterologist, specializing in the care of patients with IBD.
National representative of Germany @ https://t.co/Qr0PthTmU8 ex @Y_ECCO_IBD chair